Stem cells Archives

Latest Posts

News and Trends 24 Jan 2015

Important Bilateral Academic Agreement for the Future of iPS Cell Therapy

The UK Cell Therapy programme Catapult, which is focused on the development of the UK cell therapy industry to increase the nation’s health and wealth, has signed a patent licence agreement with iPS Academia Japan. It represents a pivotal step in the development of the UK’s GMP induced pluripotent stem (iPS) cell bank. Under the […]

January 24, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 28 Oct 2014

Stem Cell Therapy for Degenerative Muscle Disease thanks to ENDOSTEM Project

ENDOSTEM project aims to identify an agent capable of ‘boosting’ stem cells already present in muscle tissue for a more efficient tissue repair to tackle degenerative muscle disease. Muscular dystrophy is a type of degenerative muscle disease. One of its most known forms, Duchenne muscular dystrophy, affects 1 over 3 500 boys worldwide. It affects patients progressively, they […]

October 28, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 25 Oct 2014

Belgian Promethera received approval to start World first Phase IIb/III stem-cell based urea cycle disorders treatment

Promethera is a promising Belgian Biotechnology company developing stem-cell based treatment against liver diseases. It was created in 2009, counts 44 employees and has raised €39M. The company now moves to another level by starting its own Phase IIb/III to treat paediatric patients with urea cycle disorders. It is the first company in the World […]

October 25, 2014 - 1 minutemin - By Philip Hemme

News and Trends 25 Aug 2014

The new strategy of Novartis to acquire Gamida Cell

The deal for the sale of Gamida Cell to Novartis is back on. Instead of a huge exit in hundreds of millions of dollars, this time the deal is in multiple stages, starting with an injection of several dozen millions of dollars into the company. Gamida Cell, developer of a stem-cell treatment for blood cancer, announced today that it […]

August 25, 2014 - 2 minutesmins - By Joachim Eeckhout

News and Trends 21 Aug 2014

Stemedica International succeed in a pre-clinical trial to treat Alzheimer’s disease with stem cells

Stemedica International, a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease and dementia, revealed the first results of an intravenous administration of allogeneic, human, ischemia-tolerant mesenchymal stem cells (itMSCs) in a pre-clinical animal model of Alzheimer’s disease. The results demonstrated a greater than 30% decrease in amyloid beta (Abeta) plaques in […]

August 21, 2014 - 2 minutesmins - By Joachim Eeckhout

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us